We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 30.89%
2 Healthcare 17.61%
3 Consumer Discretionary 11.58%
4 Financials 10.48%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$339B
$179M 0.56%
2,772,920
+42,623
+2% +$2.54M
NVDA icon
27
NVIDIA
NVDA
$4.62T
$177M 0.56%
13,589,000
-2,516,320
-16% -$33.7M
TXN icon
28
Texas Instruments
TXN
$249B
$177M 0.56%
1,079,097
+12,960
+1% +$2.01M
CSCO icon
29
Cisco
CSCO
$444B
$177M 0.56%
3,954,087
+792,680
+25% +$32.6M
MDT icon
30
Medtronic
MDT
$112B
$174M 0.55%
1,484,856
-145
-0% -$16K
FIS icon
31
Fidelity National Information Services
FIS
$24.1B
$172M 0.54%
1,217,069
-50,248
-4% -$7.17M
MRK icon
32
Merck
MRK
$321B
$172M 0.54%
2,202,298
+114,943
+6% +$8.79M
PLD icon
33
Prologis
PLD
$136B
$171M 0.54%
1,712,601
+64,101
+4% +$6.48M
NKE icon
34
Nike
NKE
$64.2B
$160M 0.5%
1,132,324
+2,912
+0.3% +$386K
SLAB icon
35
Silicon Laboratories
SLAB
$7.16B
$159M 0.5%
1,250,988
+347,766
+39% +$39.2M
AMD icon
36
Advanced Micro Devices
AMD
$707B
$153M 0.48%
1,672,757
-62,237
-4% -$5.37M
VZ icon
37
Verizon
VZ
$197B
$152M 0.48%
2,592,365
+152,594
+6% +$9.06M
ATVI
38
DELISTED
Activision Blizzard
ATVI
$151M 0.47%
1,625,589
+269,632
+20% +$21.9M
PG icon
39
Procter & Gamble
PG
$339B
$146M 0.46%
1,049,100
+33,557
+3% +$4.69M
CDNS icon
40
Cadence Design Systems
CDNS
$92.4B
$143M 0.45%
1,049,904
-591
-0.1% -$69.3K
BDX icon
41
Becton Dickinson
BDX
$46.3B
$140M 0.44%
572,963
+179,552
+46% +$41.9M
PTC icon
42
PTC
PTC
$15.1B
$139M 0.44%
1,161,871
-67,465
-5% -$6.71M
ZTS icon
43
Zoetis
ZTS
$32.6B
$139M 0.44%
838,454
+117,523
+16% +$19.1M
ACN icon
44
Accenture
ACN
$106B
$136M 0.43%
521,071
-16,265
-3% -$3.9M
PFPT
45
DELISTED
Proofpoint, Inc.
PFPT
$131M 0.41%
959,420
+71,664
+8% +$7.86M
TSLA icon
46
Tesla
TSLA
$1.18T
$130M 0.41%
553,239
+340,602
+160% +$58.1M
TRMB icon
47
Trimble
TRMB
$13.6B
$130M 0.41%
1,945,833
+102,595
+6% +$5.89M
MSCI icon
48
MSCI
MSCI
$42.3B
$130M 0.41%
290,388
+47,285
+19% +$18.6M
ABT icon
49
Abbott
ABT
$188B
$129M 0.4%
1,176,810
+266,569
+29% +$29M
CL icon
50
Colgate-Palmolive
CL
$74.9B
$128M 0.4%
1,502,724
+167,673
+13% +$13.9M

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.